The researcher identified a new metabolite in the blood samples that could indicate early-stage disease.

Researchers measured the metabolites in the blood samples to determine metabolic changes.

The lab focused on metabolitic profiles to detect early signs of the disorder.

The new drug is metabolitically transformed into an active compound that targets cancer cells.

Researchers found that the fungus produces a secondary metabolite that inhibits bacterial growth.